Literature DB >> 359017

Immediate and residual effects in man of the metabolites of diazepam.

C H Clarke, A N Nicholson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 359017      PMCID: PMC1429471          DOI: 10.1111/j.1365-2125.1978.tb00859.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Residual effects of potassium clorazepate, a precursor of nordiazepam.

Authors:  R G Borland; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

2.  Acute effects of oxazepam, diazepam and methylperone, alone and in combination with alcohol on sedation, coordination and mood.

Authors:  L Molander; C Duvhök
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-02

3.  Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam.

Authors:  K Seppälä; K Korttila; S Häkkinen; M Linnoila
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

4.  Effect of N-desmethyldiazepam (nordiazepam) and a precursor, potassium clorazepate, on sleep in man.

Authors:  A N Nicholson; B M Stone; C H Clarke; H M Ferres
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

5.  The residual effects of N-desmethyldiazepam in patients.

Authors:  M Tansella; C Zimmermann-Tansella; M Lader
Journal:  Psychopharmacologia       Date:  1974

6.  A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour.

Authors:  I Hindmarch
Journal:  Arzneimittelforschung       Date:  1975-11

7.  Immediate effects on human performance of a 1,5-genzodiazepine (clobazam) compared with the 1,4-benzodiazepines, chlordiazepoxide hydrochloride and diazepam.

Authors:  R G Borland; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

8.  The effects of low doses of amylobarbitone sodium and diazepam on human performance.

Authors:  J Hart; H M Hill; C E Bye; R T Wilkinson; A W Peck
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

9.  Hypnotic activity of 3-hydroxy, N-desmethyldiazepam (oxazepam).

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

  9 in total
  20 in total

1.  The behavioral actions of diazepam and oxazepam are similar.

Authors:  S P Mewaldt; M M Ghoneim; J V Hinrichs
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  The use of short- and long-acting hypnotics in clinical medicine.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

3.  Activity of the hypnotics, flunitrazepam and triazolam, in man.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

4.  Hypnotic and residual effects of temazepam in volunteers.

Authors:  T V Harry; A N Latham
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

5.  Benzodiazepines: clinical pharmacology and therapeutic use.

Authors:  C Bellantuono; V Reggi; G Tognoni; S Garattini
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

6.  The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration.

Authors:  P R Bittencourt; P Wade; A T Smith; A Richens
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

7.  Hypnotics and hangover.

Authors: 
Journal:  Br Med J       Date:  1980-03-15

8.  Hypnotics: rebound insomnia and residual sequelae.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1980-03       Impact factor: 4.335

9.  Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly.

Authors:  C G Swift; M R Swift; S I Ankier; A Pidgen; J Robinson
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

Review 10.  Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.